Showing results (2231-2240 of 2,459) with videos related to
Sort By:
Pageof 246
Plos Pathogens|June 28, 2022
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivoChristian Heuss, Paul Rothhaar, Rani Burm, et al.Neuro-Oncology|March 28, 2020
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical dataJian Peng, Hao Zhou, Oliver Tang, et al.Redox Biology|April 12, 2022
Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagyYing Jiang, Sarah Krantz, Xiang Qin, et al.Science Immunology|September 17, 2017
KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-CMohammed M Naiyer, Sorcha A Cassidy, Andrea Magri, et al.Journal of Virology|November 9, 2022
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon ResistanceMaria Jose Lista, Helena Winstone, Harry D Wilson, et al.Journal of Medicinal Chemistry|February 5, 2015
Nitrocobinamide, a new cyanide antidote that can be administered by intramuscular injectionAdriano Chan, Jingjing Jiang, Alla Fridman, et al.Transplantation Proceedings|September 24, 2021
Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplantation? A Multicenter Comparative Analysis from IndiaHari Shankar Meshram, Vivek B Kute, Himanshu V Patel, et al.Circulation. Heart Failure|April 13, 2018
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart DiseaseEmmanouil Tampakakis, Sanjiv J Shah, Barry A Borlaug, et al.British Journal of Pharmacology|March 23, 2024
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in reviewAndreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.Nature Microbiology|January 16, 2024
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsAnn-Kathrin Reuschl, Lucy G Thorne, Matthew V X Whelan, et al.Pageof 246